Preventing Ovarian Hyperstimulation Syndrome in Women With PCOS During IVF
Compares two IVF drug protocols to prevent ovarian hyperstimulation syndrome in women with PCOS.
Plain-language title generated from the registry record
Registry title: Ovarian Hyperstimulation Syndrome Prevention
Key facts
- Where
- Giza, EgyptSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with PCOS who are coming for ICSI (a fertility treatment). It tests ways to prevent ovarian hyperstimulation syndrome.
- Age
- 19 Years to 42 Years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome (PCOS)
Main reasons for not taking part
- Women who do not have PCOS
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 42 years old?
Source: NCT06739759, who can take part
Where in Egypt
- AlgazeerahGiza, EgyptContact: Mahmoud Alalfy, masterTaking people
- Aljazeerah hospitalGiza, EgyptContact: Mahmoud Alalfy, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aljazeera Hospital
- Trial code
- NCT06739759
- Record updated
- 18 December 2024
- Original description
Ovarian hyperstimulation is a very hazardous complication of ICSIRead full original descriptionShow less
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
Ovarian hyperstimulation is a very hazardous complication of ICSI
Inclusion: Women with PCOS coming for ICSI.
Exclusion: Women who donnot have PCOS.